{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:28:01Z","timestamp":1787023681505,"version":"build-2736575974"},"reference-count":38,"publisher":"Impact Journals, LLC","issue":"54","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,11,3]]},"DOI":"10.18632\/oncotarget.21251","type":"journal-article","created":{"date-parts":[[2017,9,24]],"date-time":"2017-09-24T04:18:23Z","timestamp":1506226703000},"page":"92312-92323","source":"Crossref","is-referenced-by-count":14,"title":["Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma"],"prefix":"10.18632","volume":"8","author":[{"given":"Yu Ri","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Jeong","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June-Won","family":"Cheong","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haerim","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Jang","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundeok","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Ick","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Hong","family":"Min","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Seok","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,9,23]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project","volume":"9","author":"Weisenburger","year":"1998","journal-title":"Ann Oncol"},{"key":"2","doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997; 89:3909\u20133918.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"3","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Weisenburger","year":"2008","journal-title":"J Clin Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non- Hodgkin's lymphoma","volume":"329","author":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.V106.11.811.811","article-title":"International Peripheral T-Cell Lymphoma (PTCL) Clinical and Pathologic Review Project: Poor Outcome by Prognostic Indices and Lack of Efficacy with Anthracyclines","volume":"106","author":"Vose","year":"2005","journal-title":"Blood"},{"key":"6","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Pileri","year":"2006","journal-title":"J Clin Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Rigacci","year":"2004","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Rickinson","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nri1201","article-title":"B cells under influence: transformation of B cells by Epstein-Barr virus","volume":"3","author":"Kuppers","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(03)12271-4","article-title":"Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma","volume":"361","author":"Delecluse","year":"2003","journal-title":"Lancet"},{"key":"11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/1078-0432.CCR-05-2008","article-title":"Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma","volume":"12","author":"Gill","year":"2006","journal-title":"Clin Cancer Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1158\/1078-0432.CCR-10-3327","article-title":"The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma","volume":"17","author":"Larocca","year":"2011","journal-title":"Clin Cancer Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","article-title":"Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type","volume":"118","author":"Nakamura","year":"2011","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","article-title":"Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients","volume":"104","author":"Kwong","year":"2004","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00277-016-2610-5","article-title":"Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma","volume":"95","author":"Suh","year":"2016","journal-title":"Ann Hematol"},{"key":"16","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3109\/10428194.2015.1072766","article-title":"Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma","volume":"57","author":"Hohaus","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"17","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2006-04-017632","article-title":"Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study","volume":"108","author":"Gaulard","year":"2006","journal-title":"Blood"},{"key":"18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00277-014-2188-8","article-title":"Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients","volume":"94","author":"Zhao","year":"2015","journal-title":"Ann Hematol"},{"key":"19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcv.2007.08.013","article-title":"Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases","volume":"40","author":"Mitarnun","year":"2007","journal-title":"J Clin Virol"},{"key":"20","first-page":"1045","article-title":"Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis","volume":"87","author":"Mortensen","year":"1996","journal-title":"Danish Lymphoma Study Group, LYFO. Blood"},{"key":"21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM198803243181203","article-title":"T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections","volume":"318","author":"Sklar","year":"1988","journal-title":"N Engl J Med"},{"key":"22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.prp.2013.04.013","article-title":"Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study","volume":"209","author":"Ko","year":"2013","journal-title":"Pathol Res Pract"},{"key":"23","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1158\/0008-5472.CAN-04-0733","article-title":"Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction","volume":"64","author":"Takada","year":"2004","journal-title":"Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","article-title":"Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10","volume":"99","author":"Dogan","year":"2002","journal-title":"Blood"},{"key":"25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1600-0609.2011.01597.x","article-title":"Presence of B-cell clones in T-cell lymphoma","volume":"86","author":"Aozasa","year":"2011","journal-title":"Eur J Haematol"},{"key":"26","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Jaffe","year":"2016","journal-title":"Blood"},{"key":"27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2559.2012.04199.x","article-title":"Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases","volume":"61","author":"Nakamura","year":"2012","journal-title":"Histopathology"},{"key":"28","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12185-015-1763-7","article-title":"Analysis of clinical characteristics and prognostic factors for angioimmunoblastic T-cell lymphoma","volume":"101","author":"Ishida","year":"2015","journal-title":"Int J Hematol"},{"key":"29","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3109\/10428190903318311","article-title":"Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy","volume":"50","author":"Morishima","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"30","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE transactions on automatic control"},{"key":"31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Mark","year":"1996","journal-title":"Stat Med"},{"key":"32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcv.2003.10.002","article-title":"Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma","volume":"30","author":"Morand","year":"2004","journal-title":"J Clin Virol"},{"key":"33","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1373\/clinchem.2004.036640","article-title":"Distribution of cell-free and cell-associated Epstein-Barr virus (EBV) DNA in the blood of patients with nasopharyngeal carcinoma and EBV-associated lymphoma","volume":"50","author":"Lo","year":"2004","journal-title":"Clin Chem"},{"key":"34","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1158\/1078-0432.CCR-12-1064","article-title":"Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type","volume":"18","author":"Kobayashi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/jmv.23858","article-title":"Comparison of EBV DNA viral load in whole blood, plasma, B-cells and B-cell culture supernatant","volume":"86","author":"Tuaillon","year":"2014","journal-title":"J Med Virol"},{"key":"36","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1111\/j.1751-553X.2009.01171.x","article-title":"Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma","volume":"32","author":"Lee","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"37","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Hiddemann","year":"1999","journal-title":"J Clin Oncol"},{"key":"38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Lister","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.21251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T13:56:49Z","timestamp":1596722209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.21251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,23]]},"references-count":38,"journal-issue":{"issue":"54","published-print":{"date-parts":[[2017,11,3]]}},"alternative-id":["21251","29190917"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.21251","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,23]]}}}